CEO of Varian Medical Systems brings deep knowledge of the healthcare
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 18, 2018--
Agilent Technologies, Inc. (NYSE: A) today announced that Dow R. Wilson,
CEO of Varian Medical Systems, Inc., has been elected to its board of
directors, effective March 20, 2018.
Since 2012 Wilson has been CEO of Varian Medical, a Palo Alto,
Calif-based medical device and software products company for treating
cancer. Prior to his appointment as CEO, Wilson was chief operating
officer and executive vice president, and before that he was president
of Varian Medical’s Oncology Systems business.
Wilson also had a 19-year career with GE Healthcare, culminating in his
position as CEO of GE’s Healthcare Information Technology unit.
“Dow brings an important breadth of experience in the healthcare
industry. He is a well-respected leader, who is skilled at identifying
new opportunities, and building new businesses,” said Mike McMullen,
Agilent’s president and CEO. “His insights about healthcare trends
worldwide will be particularly valuable as Agilent continues to expand
in this field globally.”
“I am very pleased to welcome Dow to the Agilent board,” said Koh Boon
Hwee, Agilent chairman. “He adds an important and well-informed
perspective about the medical technology needs of customers and about
emerging markets. I look forward to working with him.”
Wilson is also a member of the Board of Directors of AdvaMed, a U.S.
trade association representing 80 percent of the medical technology
firms in the U.S., and Varex Imaging Corporation, which was created
through the successful spin-off of Varian Medical. His term on the Varex
board naturally ends in February 2018. Formerly, Wilson was lead
independent director of Saba Software, Inc.
In 2014, he was appointed by then-U.S. Secretary of Commerce, Penny
Pritzker, to the newly formed President’s Advisory Council on Doing
Business in Africa.
Wilson received an MBA from the Tuck School of Business at Dartmouth
College, New Hampshire and a Bachelor of Arts degree from Brigham Young
“I have long admired Agilent’s scientific solutions, as well as its
strong customer focus and impeccable reputation for integrity. I am very
pleased to be joining Agilent’s board at this exciting time as the
company continues its expansion into medical healthcare,” Wilson said.
Agilent Technologies, Inc. (NYSE: A), a global leader in life sciences,
diagnostics and applied chemical markets, working with customers in more
than 100 countries, providing instruments, software, services and
consumables for the entire laboratory workflow. The company generated
revenues of $4.5 billion in fiscal 2017 and employs about 13,500 people
worldwide. Information about Agilent is available at www.agilent.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180118006286/en/
Source: Agilent Technologies, Inc.
Stefanie Notaney, +1 408-345-8955
408-508-9369 - mobile